# Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration

> **NCT01737944** · PHASE1,PHASE2 · COMPLETED · sponsor: **Antares Pharma Inc.** · enrollment: 38 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate (MTX)

## Key facts

- **NCT ID:** NCT01737944
- **Lead sponsor:** Antares Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737944, "Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01737944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*